1. Stevenson F.K., George A.J.T., Walters M.T. and Hamblin T.J.

Analysis of soluble HLA Class II antigenic material in patients with immunological diseases using monoclonal antibodies.

Journal of Immunological Methods, (1986); 86: 187-190.


  1. George A.J.T., Tutt A.L. and Stevenson F.K.

Anti-idiotypic mechanisms involved in suppression of a mouse B-cell lymphoma BCL1.

Journal of Immunology, (1987); 138: 628-634.


  1. George A.J.T., Spellerberg M.B. and Stevenson F.K.

Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.

Journal of Immunology, (1988); 140: 1695-1701.


  1. George A.J.T., Folkard S.G., Hamblin T.J. and Stevenson F.K.

Idiotype vaccination as a treatment for a B cell lymphoma.

Journal of Immunology, (1988); 141: 2168-2174.


  1. George A.J.T. and Stevenson F.K.

Humoral effector mechanisms in the immunity to cancer (letter).

Immunology Today, (1990); 11: 348-349.


  1. Wilson A., George A.J.T., King C.A. and Stevenson F.K.

Recognition of a B-cell lymphoma by anti-idiotypic T cells.

         Journal of Immunology, (1990); 145: 3937-3943.


  1. Dyke R.J., McBride H.M., George A.J.T., Hamblin T.J. and Stevenson F.K.

Idiotypic vaccination against B-cell lymphoma leads to dormant tumour.

Cellular Immunology, (1991); 132: 70-83.


  1. George A.J.T., Foreman R.C. and Stevenson F.K.

Characterisation of a light chain loss variant of the BCL1 lymphoma.

Molecular Immunology, (1991); 28: 789-799.


  1. George A.J.T., McBride H.M., Glennie M.J., Smith L.J. and Stevenson F.K.

Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants.

Hybridoma, (1991); 10: 219-227.


  1. Urch C.E., George A.J.T., Stevenson G.T., Bolognesi A., Stirpe F., Weller R. and Glennie M.J.

Intra-thecal treatment of leptomeningeal lymphoma with immunotoxin.

International Journal of Cancer (1991); 47: 909-915.


  1. Greenman J., Tutt A.L., George A.J.T., Pulford K.A.F., Stevenson G.T. and Glennie M.J.

Characterization of a new monoclonal anti-FcgRII antibody, AT10, and its incorporation into a bispecific F(ab´)2 derivative for recruitment of cytotoxic effectors.

Molecular Immunology (1991); 28: 1243-1254.


  1. Kurucz I., Jost C.R., George A.J.T., Andrew S.M. and Segal D.M.

A bacterially-expressed single chain Fv construct from the 2B4 T cell receptor.

Proceedings of the National Academy of Sciences (U.S.A.), (1993); 90: 3830-3834.


  1. George A.J.T., Titus J.A., Jost C.R., Kurucz I., Perez P., Andrew S.M., Nicholls P.J., Huston J.S. and Segal D.M.

Redirection of T cell mediated cytotoxicity by a recombinant single-chain Fv molecule.

Journal of Immunology, (1994); 152:1802-1811.


  1. Jost C.R., Kurucz I., Jacobus C.M., Titus J.A., George A.J.T. and Segal D.M.

Mammalian expression and secretion of functional single-chain Fv molecules.

Journal of Biological Chemistry, (1994); 269: 26267-26273.


  1. George A.J.T.

Surface bound cytokines — a possible effector mechanism in bacterial immunity (letter).

Immunology Today, (1994); 15: 88-89.


  1. Barboni E., Pliego Rivero B., George A.J.T., Martin S.R., Renouf D.V., Hounsell E.F., Barber P.C. and Morris R.J.

The glycophosphatidylinositol anchor affects the conformation of Thy-1 protein.

Journal of Cell Science, (1995); 108: 487-497.


  1. George A.J.T., French R.R. and Glennie M.J.

Measurement of kinetic binding constants of a panel of anti-saporin antibodies using a resonant mirror biosensor.

Journal of Immunological Methods, (1995); 183: 51-63.


  1. French R.R., Penney C.A., Browning A., Stirpe F., Tutt A.L., George A.J.T. and Glennie M.J.

Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.

British Journal of Cancer, (1995); 71: 986-994.


  1. George A.J.T., Jamar F., Tai M.-S., Heelan B.T., Adams G.P., McCartney J.E., Houston L.L., Weiner L.M., Oppermann H., Peters A.M. and Huston J.S.

Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.

Proceedings of the National Academy of Sciences (USA), (1995); 92: 8358-8363.


  1. George A.J.T., Danga R., Gooden C.S.R., Epenetos A.A. and Spooner R.A.

Quantitative and qualitative detection of serum antibodies using a resonant mirror biosensor.

Tumor Targeting, (1995); 1: 245-250.


  1. Boleti E., Deonarain M.P., Spooner R.A., Smith A.J., Epenetos A.A., and George A.J.T.

Construction, expression and characterisation of a single chain anti-tumour antibody (scFv)-IL-2 fusion protein.

Annals of Oncology, (1995); 6: 945-947.


  1. Larkin D.F.P., Oral H.B., Ring C.J.A., Lemoine N.R. and George A.J.T.

Adenovirus-mediated gene delivery to the corneal endothelium.

Transplantation, (1996); 61: 363-370.


  1. George A.J.T. and Ritter M.A.

Thymic involution with ageing: obsolescence or good housekeeping?

Immunology Today, (1996); 17: 267-272.


  1. Heelan B.T., Thompson M., McCormack A, Peters A.M., Batchelor J.R. and George A.J.T.

The kinetics of MHC class I and class II expression in rat renal allografts: in vivo localization with radiolabelled antibodies.

Transplantation, (1996); 61: 1274-1277.


  1. Levy J.B., Turner A.N., George A.J.T. and Pusey C.D.

Epitope analysis of the Goodpasture antigen using a resonant mirror biosensor.

Clinical and Experimental Immunology, (1996); 106: 79-85.


  1. Kuyama J., McCormack A., George A.J.T., Heelan B.T., Osman S., Batchelor J.R. and Peters A.M.

Indium-111 labeled lymphocytes: isotope distribution and cell division.

European Journal of Nuclear Medicine, (1997); 24: 488-496.


  1. Turner D.J., Ritter M.A. and George A.J.T.

Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology.

Journal of Immunological Methods, (1997); 205: 43-54.


  1. Deonarain M.P., Rowlinson-Busza G., George A.J.T. and Epenetos A.A.

Redesigned soluble expression, characterisation and in vivo tumour targeting of an anti-human placental alkaline phosphatase single-chain Fv.

Protein Engineering, (1997); 10: 89-98.


  1. Palmer D.B., George A.J.T. and Ritter M.A.

Selection of antibodies to cell surface determinants on mouse thymic epithelial cells using a phage display library.

Immunology, (1997); 91: 473-478.


  1. Fehervari Z., Rayner S.A., Oral H.B., George A.J.T. and Larkin D.F.P.

Gene transfer to ex vivo stored corneas.

Cornea, (1997); 16: 459-464.


  1. Oral H.B., Larkin D.F.P., Fehervari Z., Byrnes A.P., Rankin A.M., Haskard D.O., Wood M.J.A., Dallman M.J. and George A.J.T.

Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea.

Gene Therapy, (1997); 4: 639-647.


  1. Harrison A.A., Stocker C.J., Chapman P.T., Tsang Y.T., Heuhns T.Y., Gundel R.H., Peters A.M., Davies K.A., George A.J.T., Robinson M.K. and Haskard D.O.

Expression of VCAM-1 by vascular endothelial cells in immune- and non-immune inflammatory reactions in the skin.

Journal of Immunology, (1997); 159: 4546-4554.


  1. Rayner S.A., Gallop J.L., George A.J.T. and Larkin D.F.P.

Distribution of integrins avb5, avb3 and av in normal human cornea: implications in clinical and therapeutic adenoviral infection.

Eye, (1998); 12: 273-277.


  1. Arancibia-Cárcamo C.V., Oral H.B., Haskard D.O., Larkin D.F.P. and George A.J.T.

Lipoadenofection mediated gene delivery to the corneal endothelium: prospects for modulating graft rejection.

Transplantation, (1998); 65: 62-67.


  1. Patel M.J., Webb E.J., Shelbourn T.E., Mattia-Goldberg C., George A.J.T., Zhang F., Moore E.G. and Nelson D.J.

Absence of immunogenicity of diaspirin crosslinked hemoglobin in humans.

Blood, (1998); 91: 710-716.


  1. Hart S.L., Arancibia-Cárcamo C.V., Wolfert M.A., Mailhos C., O’Reilly N.J., Ali R.R., Coutelle C., George A.J.T., Harbottle R.P., Knight A.M., Larkin D.F.P., Levinsky R.J., Seymour L.W., Thrasher A.J. and Kinnon C.

Lipid-mediated enhancement of transfection by a non-viral integrin-targeting vector.

Human Gene Therapy, (1998); 9: 575-585.


  1. Mahiouz D.L., Aichinger G., Haskard D.O. and George A.J.T.

Expression of recombinant anti-E-selectin single-chain Fv antibody fragments in stably transfected insect cell lines.

Journal of Immunological Methods, (1998); 212: 149-160.


  1. Reisbeck K., Chen D., Kemball-Cook G., McVey J.H., George A.J.T., Tuddenham E.G.D., Dorling A. and Lechler R.I.

Hirudin expressed in mammalian cells and tethered to the cell surface confers thrombin binding activity.

Circulation, (1998); 98: 2744-2752.


  1. Heelan B.T., Osman S., Blyth A., Schnoor L., Jones T., and George A.J.T.

The use of 2-[18F] fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography.

Transplantation, (1998); 66: 1101-1103.


  1. Oral H.B., George A.J.T., and Haskard D.O.

A sensitive fluorometric assay for determining hydrogen peroxide-mediated sublethal and lethal endothelial cell injury.

Endothelium, (1998); 6: 143-151.


  1. Hussain R., Siligardi G., George A.J.T. and Verma R.

Immobilised and non-immobilised ligand interaction studies of monoclonal antibody BC-1 and ED-B containing fibronectin fragment.

         Protein and Peptide Letters, (1998); 5: 215-219.


  1. Lee J., Cairns T., McKane W., Rashid M., George A.J.T. and Taube D.

Demonstration of IgM antibodies of high affinity within the anti-Gala1-3Gal antibody repertoire.

Transplantation, (1998); 66: 1117-1119.


  1. McKay P.F., Imami N., Johns M., Taylor-Fishwick D.A., Sedibane L.M., Totty N.F., Hsuan J.J., Palmer D.B., George A.J.T., Foxwell B.M.J. and Ritter M.A.

The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family.

European Journal of Immunology, (1998); 28: 4071-4083.


  1. Lord G.M., Lechler R.I. and George A.J.T.

A kinetic differentiation model for the action of altered T cell receptor ligands.

Immunology Today, (1999): 20: 33-39.


  1. Nicholson S., Gallop J.L., Law P., Thomas H and George A.J.T.

Monitoring antibody responses to cancer vaccination with a resonant mirror biosensor.

Lancet, (1999); 353: 808.


  1. Verma R., George A.J.T. and Courtenay-Luck N.S.

Generation of a single-chain Fv (sFv) against an oncofoetal antigen associated with tumourigenesis and angiogenesis.

Journal of the International Society of Tumour Targeting; (1999); 1: 9-21.


  1. Oral H.B., Arancibia-Cárcamo C.V., Haskard D.O. and George A.J.T.

A method for determining the cytoprotective effect of catalase in transiently transfected cell lines and in corneal tissue.

Analytical Biochemistry, (1999); 267: 196-202.


  1. Palmer D.B., Crompton T., Marandi M.B., George A.J.T. and Ritter M.A.

Intrathymic function of the human cortical epithelial cell surface antigen gp200-MR6: single chain antibodies to evolutionarily conserved determinants disrupt mouse thymus development.

Immunology, (1999); 96: 236-245.


  1. George A.J.T. and Gray D.

Receptor editing during affinity maturation: taking large leaps through the landscape.

Immunology Today, (1999); 20: 196.


  1. Hudde T., Rayner S.A., Comer R.M., Weber M., Isaacs J.D., Waldmann H., Larkin D.F.P. and George A.J.T.

Activated polyamidoamine dendrimers, a non viral vector for gene transfer to the corneal endothelium.

Gene Therapy (1999); 6: 939-943.


  1. Sepp A., Farrar T., Dorling A., Cairns T., George A.J.T. and Lechler R.I.

Inhibition of expression of Gala1-3Gal epitope on porcine cells using an intracellular single-chain antibody directed against a1,3Galactosyltransferase.

Journal of Immunological Methods (1999); 231: 191-205.


  1. Callard R., George A.J.T. and Stark J.

Cytokines, chaos and complexity.

Immunity (1999); 11: 507-513.


  1. Chan C.C.W., Stark J. and George A.J.T.

Analysis of cytokine dynamics in corneal allograft rejection.

Proceedings of the Royal Society (London) Series B (1999); 266: 2217-2223.


  1. Hudde T., Rayner S.A., De Alwis M., Thrasher A.J., Smith J., Coffin R.S., George A.J.T. and Larkin D.F.P.

Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium

Cornea (2000); 19: 369-373.


  1. Rayner S.A., King W.J., Comer R.M., Isaacs J.D., Hale G., George A.J.T. and Larkin D.F.P.

Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation

Clinical Experimental Immunology, (2000); 122: 109-116.


  1. Oral H.B., George A.J.T. and Haskard D.O.

Prevention of hydrogen peroxide- and cisplatin- induced apoptosis by intracellular catalase expression.

Turkish Journal of Biology (2000); 24: 685-696.


  1. Midulla M., Verma R., Pignatelli M., Ritter M.A., Courtenay-Luck N.S. and George A.J.T.

Source of the oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells.

Cancer Research, (2000); 60: 164-169.


  1. Johns M., George A.J.T. and Ritter M.A.

In vivo selection of sFv from phage display libraries

Journal of Immunological Methods, (2000); 239: 137-151.


  1. King W.J., Comer R.M., Hudde T., Larkin D.F.P. and George A.J.T.

Cytokine and chemokine expression kinetics following corneal transplantation.

Transplantation, (2000); 70: 1225-1233.


  1. Griffith M.E., Coulthart A., Pemberton S., George A.J.T. and Pusey C.D.

Anti-neutrophil cytoplasm antibodies from patients with systemic vasculitis recognise restricted epitopes of proteinase 3 involving the catalytic site.

Clinical Experimental Immunology, (2001); 123: 170-177.


  1. Tan P.H., King W.J., Chen D., Awad H., Mackett M., Lechler R.I., Larkin D.F.P. and George A.J.T.

Transferrin receptor mediated gene transfer to the corneal endothelium.

Transplantation, (2001); 71: 552-560.


  1. Rayner S.A., Larkin D.F.P. and George A.J.T.

TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival.

         Investigative Ophthalmology & Visual Science, (2001); 42: 1568-1673.


  1. Chan C., George A.J.T. and Stark J.

Cooperative enhancement of specificity in a lattice of T cell receptors.

         Proceedings National Academy of Sciences (USA), (2001); 98: 5758-5763.


  1. Comer R.M., King W.J., Ardjomand N., Theoharis S., George A.J.T. and Larkin D.F.P.

Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft suvival.

Investigative Ophthalmology & Visual Science, (2002); 43: 1095-1103.


  1. Hudde T., Comer R.M., Kinsella M.T., Buttery L., Luthert P.J., Polak J.M., George A.J.T. and Larkin D.F.P.

Modulation of hydrogen peroxide-induced injury to corneal endothelium by virus mediated catalase gene transfer.

British Journal of Ophthalmology, (2002); 86:1058-1062.


  1. Lee L., Buckley C., Blades M.C., Panayi G., George A.J.T. and Pitzalis C.

Idenitification of synovium-specific homing peptides by in vivo phage display selection.

Arthritis and Rheumatism, (2002); 46: 2109-2120.


  1. George A.J.T.

Is the number of genes we possess limited by the presence of an adaptive immune system?

Trends in Immunology, (2002); 23: 351-355.


  1. Salama A.D., Dougan T., Levy J.B., Cook H.T., Morgan S.H., Naudeer S., Maidment G., George A.J.T., Evans D., Lightstone L. and Pusey C.D.

Goodpasture’s disease in the absence of circulating anti-glomerular basement membrane antibodies using standard techniques.

American Journal of Kidney Diseases, (2002); 32:1162-1167.


  1. Dougan T., Levy J.B., Salama A., George A.J.T. and Pusey C.D.

Characterization of autoantibodies from patients with Goodpasture’s disease using a resonant mirror biosensor.

Clinical Experimental Immunology, (2002); 128: 555-561.


  1. Tan P.H., Manunta M., Ardjomand N., Xue S.A., Larkin D.F.P., Haskard D.O. Taylor K.M. and George A.J.T.

Antibody targeted gene transfer to endothelium.

Journal of Gene Medicine, (2003); 5: 311-323.


  1. Chan C., George A.J.T. and Stark J.

T cell sensitivity and specificity – kinetic proofreading revisited.

Discrete and Continuous Dynamical Systems, Series B, (2003); 3: 343-360.


  1. Ardjomand N., McAllister J.C., Rogers N.J., Tan P.H., George A.J.T. and Larkin D.F.P.

Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.

Investigative Ophthalmology & Visual Science, (2003); 44: 3899-3905.


  1. Chan C., Stark J. and George A.J.T.

Feedback control of T cell receptor activation.

Proc Roy Soc B, (2004); 271: 931-939.


  1. Arancibia-Cárcamo C.V., Osawa H., Arnett H.A., Háskova Z., George A.J.T., Ono S.J. Ting J P-Y, and Streilein J.W.

A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.

European Journal of Immunology, (2004); 34: 471-480.


  1. Tan P.H., Chan C., Xue S.A., Dong R., Ananthesayanan B., Manunta M., Kerouedan C., Cheshire N.J.W., Wolfe J.H., Haskard D.O., Taylor K.M., George A.J.T.

Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells.

Atherosclerosis, (2004); 173: 171-183.


  1. Nicholson S., Bomphray C.C., Thomas H., McIndoe A., Barton D., Gore M., and George A.J.T.

A Phase I trial of idiotypic vaccination with HMFG1 in Ovarian Cancer.

Cancer Immunology and Immunotherapy, (2004); 53: 809-816.


  1. Manunta M., Tan, P.H., Sagoo P. Kashefi K. and George A.J.T.

Gene delivery by dendrimers operates via a cholesterol dependent pathway.

         Nucleic Acids Research, (2004); 32: 2730-2739.


  1. Fraser S.P., Diss J.K.J., Lloyd L.J., Pani F., Chioni A-M., George A.J.T. and Djamgoz M.B.A.

T-lymphocyte invasiveness: control by voltage-gated Na+ channel activity.

         FEBS Letters, (2004); 569: 191-194.


  1. Sagoo P., Chan, G., Larkin D.F.P. and George A.J.T.

Inflammatory cytokines induce apoptosis of corneal endothelium via nitric oxide.

Investigative Ophthalmology & Visual Science (2004); 45: 3964-3973.


  1. Chan C., Stark J and George A.J.T.

The impact of multiple T cell-APC encounters and the role of anergy.

Journal of Computational and Applied Mathematics (2005); 184: 101-120.


  1. Tan P.H., Beutelspacher S.C., Wang Y-H., McClure M.O., Ritter M.A., Lombardi G. and George A.J.T.

Immunolipoplexes: an efficient, non-viral alternative for transfection of human dendritic cells with potential for clinical vaccination.

Molecular Therapy (2005); 11: 790-800.


  1. Beutelspacher S.C., Ardjomand N., Tan P.H., Patton G.S., Larkin D.F.P., George A.J.T. and McClure M.O.

Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal gene transduction.

Experimental Eye Research (2005); 80: 787-794.


  1. Tan P.H., Beutelspacher S.C., Xue S-A., Wang Y-H., Mitchell P., McAlister J.C. Larkin D.F.P., McClure M.O., Stauss H.J., Ritter M.A., Lombardi G. and George A.J.T.

Modulation of human dendritic cell function following transduction with viral vectors; implications for gene therapy.

Blood (2005); 105: 3824-3832.


  1. Tan PH, Sagoo P., Chan C., Yates J.B., Campbell J., Beutelspacher S.C., Foxwell B.M.J., Lombardi G., George A.J.T.

Inhibition of NFkB and oxidative pathways in human dendritic cells by anti-oxidative vitamins generates regulatory T cells.

         Journal of Immunology (2005); 174:7633-7644.


  1. Mirenda V., Millington O, Lechler R.I., Scott D. Hernandez-Fuentes M.P., Read J., Tan P.H., George A.J.T., Garside P., Marelli-Berg F.M.

Tolerant T cells display impaired trafficking ability.

European Journal of Immunology, (2005); 35: 2146-2156.


  1. Tan P.H., Yates J., Xue S.A., Chan C., Jordan W.R., Harper J.E., Watson M.P., Dong R., Ritter M.A., Lechler R.I., Lombardi G. and George A.J.T.

Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression.

Blood (2005); 106: 2936-2943.


  1. Kodama T., Tan P.H., Offiah I., Partridge T., Cook T., George A.J.T. and Blomley M.J.K.

Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles

Ultrasound in Medicine and Biology, (2005); 31: 1683-1691.


  1. Reynolds P.R., Larkman D.J., Haskard D.O., Hajnal J.V., Kennea N.L., George A.J.T. and Edwards A.D.

Detection of vascular expression of E-selectin in vivo with MR.

         Radiology, (2006); 241: 469-476.


  1. Tan P.H., Xue S.A. Manunta M., Beutelspacher S.C., Fazekasova H., Alam A.K.M.S., McClure M.O. and George A.J.T.

Effect of vectors on human endothelial cell signal transduction: implication for cardiovascular gene therapy.

         Arteriosclerosis, Thrombosis, and Vascular Biology, (2006); 26: 462-467.


  1. Beutelspacher S.C., Pillai R., Watson M.P., Tan P.H., Tsang J., McClure M.O., George A.J.T. and Larkin D.F.P.

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression

       European Journal of Immunology, (2006); 36: 690-700.


  1. Beutelspacher S.C., Tan P.H., McClure M.O., Larkin D.F.P., Lechler R.I., and George A.J.T.

Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses.

American Journal of Transplantation, (2006); 6: 1320-1330.


  1. Watson M.P., George A.J.T. and Larkin D.F.P.

Differential effects of costimulatory pathway modulation on corneal allograft survival.

         Investigative Ophthalmology & Visual Science, (2006); 47: 3417-3422.


  1. Buckland M., Jago C.B., Fazekasova H., Scott K., Tan P.H., George A.J.T., Lechler R.I. and Lombardi G.

Aspirin-treated human DCs upregulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells

         American Journal of Transplantation, (2006); 6: 2046-2059.


  1. Garden O.A., Reynolds P.R., Yates J., Larkman D.J., Marelli-Berg F.M., Haskard D.O. Edwards A.D. and George A.J.T.

A rapid method for labelling CD4+ T cells with ultrasmall paramagnetic iron oxide nanoparticles for magnetic resonance imaging that preserves proliferative, regulatory and migratory behaviour in vitro.

         Journal of Immunological Methods, (2006); 314: 123-133.


  1. Manunta M., Nicholls B.J., Tan P.H., Sagoo P., Harper J. and George A.J.T.

Gene delivery by dendrimers operates via different pathways in different cells, but is enhanced by the presence of caveolin.

         Journal of Immunological Methods, (2006); 314: 134-146.


  1. Alam A.K.M.S., Florey O., Weber M., Pillai R.G., Chan C., Tan P.H., Lechler R.I., McClure M.O. Haskard D.O. and George A.J.T.

Knockdown of mouse VCAM-1 by vector-based siRNA.

Transplantation Immunology, (2006); 16: 185-193.


  1. Soleimani B., Katopodis A., Wieczorek G., George A.J.T., Hornick P.I. and Heusser C.

Smooth muscle cell proliferation but not neoitimal formation is dependent on alloantibody in a murine model of intimal hyperplasia.

Clinical Experimental Immunology, (2006); 146: 509-517.


  1. Buckland M., Jago C., Fazekesova H., George A., Lechler R. and Lombardi G.

Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T cells.

International Immunopharmacology (2006); 6: 1895-1901.


  1. Chan C., George A.J.T. and Stark J.

Cytotoxic killing and immune evasion by repair

Journal of Statistical Physics, (2007); 128: 393-411.


  1. Tamir A., Basagila E., Kagahzian A., Jiao L., Jensen S., Nicholls J., Tate P., Stamp G., Farzaneh F., Harrison P., Stauss H., George A.J.T., Habib N., Lechler R.I. and Lombardi G.

Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors.

Cancer Immunology Immunotherapy, (2007); 56: 2003-2016.


  1. Tan P.H., Xue S.-A., Wei B., Holler A., Voss R.-H. and George A.J.T.

Changing viral tropism using immunoliposomes alters the stability of gene expression: implication for viral vector design.

Molecular Medicine (2007); 13: 216-236.


  1. Soleimani B., Wieczorek G., Katopodis A, Zenke G., George A.J.T., Hornick P.I. and Weitz-Schmidt G.

Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasia

Journal of Heart and Lung Transplantation (2007); 26: 724-731.


  1. Yates A., Chan C, Strid J., Moon S., Callard R., George A.J.T. and Stark J.

Reconstruction of cell population dynamics using CFSE.

BMC Bioinformatics, (2007); 8: 196.


  1. Pillai R.G., Beutelspacher S.C., Larkin D.F.P. and George A.J.T.

Upregulation of chemokine expression in murine cornea due to mechanical trauma or endotoxin.

British Journal of Ophthalmology, (2008); 92: 259-264.


  1. Pillai R.G., Beutelspacher S.C., Larkin D.F.P. and George A.J.T.

Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival.

Transplantation, (2008); 85:1640-1647.


  1. Theoharis S., Krueger U., Tan P.H., Haskard D.O., Weber M., and George A.J.T.

Targeting gene delivery to activated vascular endothelium using anti-E/P-Selectin antibody linked to PAMAM dendrimers

         Journal of Immunological Methods, (2009); 343: 79-90.


  1. 107. Fazekasova H., Golshayan D., Read J., Tsallios A., Tsang J.Y-S., Dorling A., George A.J.T., Lechler R.I., Lombardi G. and Mirenda V.

Regulation of rat and human T cell immune response by pharmacologically modified dendritic cells.

         Transplantation, (2009); 87:1617-28


  1. Seow W.Y., Yang Y.Y. and George A.J.T.

Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization.

Nucleic Acids Research, (2009); 37: 6276-6289


  1. Seow W.Y., Yang Y.Y. and George A.J.T.

Novel triblock oligopeptides as efficient nonviral vectors: characterisation and further insights.

Macromolecular Rapid Communications, (2010); 31: 1170-1174.


  1. Zaher S.S., Germain C., Fu H., Larkin D.F.P. and George A.J.T.

3-hydroxykynurenine suppresses CD4+ T cell proliferation, induces T regulatory cell development and prolongs corneal allograft survival.

Investigative Ophthalmology & Visual Science (2011); 52: 2640-2648.


  1. Iddon L., Leyton J., Indrevoll B., Glaser M., Robins E.G., George A.J.T., Cuthbertson A., Luthra S.K. and Aboagye E.O.

Synthesis and in vitro evaluation of [(18)F]fluoroethyl triazole labelled [Tyr(3)]octreotate analogues using click chemistry.

         Bioorg Med Chem Lett. (2011); 21: 3122-3127.


  1. Leyton J., Iddon L., Perumal M., Indrevoll B., Glaser M., Robins E., George A.J.T., Cutherbertson A., Luthra S.K. and Aboagye E.O.

Targeting somatostatin receptors: preclinical evaluation of novel [18F] Fluoroethyltriazol-[Tyr3]Octreotate analogs for PET.

Journal of Nuclear Medicine (2011); 52: 1441-1448.


  1. Fu H., Khan A., Coe D., Zaher S., Chai J.-G., Kropf P., Müller I., Larkin D.F.P., and George A.J.T.

Arginine depletion as a mechanism for the immune privilege of corneal allografts.

European Journal of Immunology (2011); 41: 2997-3005.


  1. Kamperidis P., Kamalati T., Ferrari M., Jones M., Garrood T., Smith M.D., Diez-Posada S., Hughes C., Finucane C., Mather S., Nissim A., George A.J.T. and Pitzalis C.

Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis.

Arthritis & Rheumatism (2011); 63: 3758-3767.


  1. Lin W., Oh S.K.W., Choo A.B.H. and George A.J.T.

Activated T cells modulate immunosuppression by embryonic- and bone marrow-derived mesenchymal stem cells through a feedback mechanism.

         Cytotherapy (2012);14: 274-84.


  1. Zaher S.S., Coe D., Chai J-G., Larkin D.F.P. and George A.J.T.

Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T cell cycle arrest.

Immunology (2013); 138: 157-164.


  1. Khan A., Fu H, Tan L.A., Harper J.E., Beutelspacher S.C., Larkin D.F.P., Lombardi G., McClure M.O. and George A.J.T.

Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition.

European Journal of Immunology (2013); 43: 734-746.


  1. Zhao H., Watts H.R., Chong M., Huang H., Tralau-Stewart C., Maxwell P.H., Maze M., George A.J.T. and Ma D.

Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats.

American Journal of Transplantation (2013); 13: 2006-2018.


  1. Zhao H., Yoshida A., Xiao W., Ologunde R., O’Dea K.P., Takata M., Tralau-Stewart C., George A.J.T. and Ma D.

Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats.

FASEB Journal (2013); 27: 4076-4088.


  1. Teo P.Y., Yang C., Hedrick J.L., Engler A.C., Coady D.J., Ghaem-Maghami S., George A.J.T. and Yang Y.Y.

Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection.

Biomaterials (2013); 34: 7971-7979.


  1. Zhao H., Luo X., Zhou A., Liu J., Tralau-Stewart C., George A.J.T. and Ma D.

Early treatment with xenon protects against cold ischemia associated with chronic allograft nephropathy in rats.

Kidney International (2013): 85: 112-123.


  1. Zhao H., Ning J., Savage S., Kang H., Lu K., Zheng X., George A.J.T. and Ma D.

A novel strategy for preserving renal allografts in an ex vivo setting: potential for enhancing the marginal donor pool.

FASEB Journal (2013); 27: 4822-4833.


  1. Maine C.J., Aziz N.H.A., Chatterjee J., Hayford C., Brewig N., Whilding L., George A.J.T. and Ghaem-Maghami S.

Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer.

Cancer Immunology Immunotherapy (2014); 63: 215-224.


  1. Zhao H., Huang H., Ologunde R., Lloyd D.G., Watts H., Vizcaychipi M.P., Lian Q., George A.J.T. and Ma D.

Xenon treatment protects against remote lung injury following kidney transplantation in rats.

Anesthesiology (2015); 122:1312-26.


  1. Mouratidis P.X.E. and George A.J.T.

Regulation of indoleamine 2,3 dioxygenase in primary human saphenous vein endothelial cells.

Journal of Inflammation Research (2015); 8: 97-106.


  1. Teo P.Y., Yang C., Whilding L.M., Parente-Pereira A.C., Maher J., George A.J.T., Hendrick J.L., Yang Y.Y. and Ghaem-Maghami S.

Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethyleimine: strategies to enhanced T cell killing.

Advanced Health Materials (2015); 4: 1180-9.


  1. Chatterjee J., Dai W., Abd Aziz N.H., Teo P.Y., Wahba J., Phelps D.L., Maine C.J., Whilding L.M., Dino R., Trevisan G., Flower K.J., George A.J.T. and Ghaem-Maghami S.

Clinical use of Programme Cell Death-1 (PD-1) and its ligand (PD-L1) expression as discriminatory and predictive markers in ovarian cancer.

Clinical Cancer Research (2016), 23: 3453-60.




  1. George A.J.T. and Urch C.E. (eds.).

Diagnostic and Therapeutic Antibodies

Humana Press, Totowa, New Jersey (2000).

ISBN: 0-89603-798-3, 477pp


Patent granted:


  1. George A.J.T., Segal D.M and Huston J.S.

Methods of delivering agents to target cells

US Patent No.: 5,861,156. Issued January 19, 1999, Filed January 8, 1993.


  1. Riesbeck K., Dorling A., George A.J.T. and Lechler R.I.

Anticoagulant fusion protein anchored to cell membrane

US Patent No.: 6,423,316. Issued July 23, 2002, Filed March 26, 1997


Patents submitted:


  1. Ramrakha P.S., Dorling A., George A.J.T. and Lechler R.I.

Methods and means to prevent cellular phase of rejection of (xeno)transplantated tissues by use of transplant tissues comprising endothelial cells which may be induced to generate a compound which down-regulates the expression of a cell adhesion molecule by the cells.

UK Application No.: 9825555.7 Filed November 20, 1998




  1. George A.J.T. and Stevenson F.K.

Prospects for the treatment of B-cell tumors using idiotypic vaccination.

International Reviews of Immunology, (1989); 4: 271-310.


  1. Stevenson F.K., George A.J.T. and Glennie M.J.

Anti-idiotypic therapy of leukemias and lymphomas.

Chemical Immunology, (1990); 48: 126-166.


  1. George A.J.T.

Regulation of the B cell response by cytokines.

Transfusion Science, (1991); 12: 43-57.


  1. George A.J.T.

Antibody engineering.

Endeavour, (1994); 18: 27-31.


  1. George A.J.T., Ritter M.A. and Lechler R.I.

Disease association, transplantation and the MHC.

Xeno, (1994); 2: 77-79.


  1. George A.J.T., Spooner R.A. and Epenetos A.A.

Applications of monoclonal antibodies in clinical oncology

Immunology Today, (1994); 15: 559-561.


  1. George A.J.T., Ritter M.A. and Lechler R.I.

Disease susceptibility, transplantation and the MHC.

Immunology Today, (1995); 16: 209-211.


  1. Boleti E., George A.J.T. and Epenetos A.A.

Therapeutic monoclonals.

Journal of Biochemical Transactions, (1995); 23: 1044-1047.


  1. George A.J.T.

Bispecific antibodies in tumour therapy.

Tumor Targeting, (1995); 1: 185-187.


  1. Hornick P. and George A.J.T.

Blood contact activation. Pathophysiological effects and therapeutic approaches.

Perfusion, (1996); 11: 3-19.


  1. Huston J.S., George A.J.T., Adams G.P., Stafford W.F., Jamar F., Tai M.-S., McCartney J.E., Oppermann H., Heelan B.T., Peters A.M., Houston L.L., Bookman M.A., Wolf E.J. and Weiner L.M.

Single-chain Fv radioimmunotargeting.

Quarterly Journal of Nuclear Medicine, (1996); 40: 320-333.


  1. George A.J.T., Huston J.S. and Haber E.

Exploring and exploiting the antibody and Ig superfamily combining sites.

Nature Biotechnology, (1996); 14: 584.


  1. George A.J.T. and Epenetos A.A.

Advances in antibody engineering.

Expert Opinion on Therapeutic Patents, (1996); 6: 441-456.


  1. George A.J.T., Rashid M. and Gallop J.L.

Kinetics of biomolecular interactions.

Expert Opinion on Therapeutic Patents, (1997); 7: 947-963.


  1. Verma R., Boleti E., and George A.J.T.

Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems.

Journal of Immunological Methods, (1998); 216: 165-181.


  1. George A.J.T.

The application of biosensor technology to the detection and characterisation of polyclonal antibody reactivity.

International Journal of Biochromatography, (1999); 4: 187-202.


  1. George A.J.T.

Peptide-mediated non-viral gene transfer for transplantation.

         Transplantation, (2000); 69: 1031-1033.


  1. George A.J.T. and Larkin D.F.P.

Corneal transplantation: prospects for gene therapy.

Eye News, (2001); 7: 36-48.


  1. Yates A., Chan C.C.W., Callard R.E., George A.J.T. and Stark J.

An approach to modelling in immunology.

         Briefings in Bioinformatics, (2001); 2: 245-257.


  1. Huston J.S. and George A.J.T.

Engineered antibodies take center stage.

Human Antibodies, (2001); 10: 127-142.


  1. George A.J.T., Gale R., Winston R. and Korn D.

Research Governance at the crossroads.

Nature Medicine, (2002); 8: 99-101.


  1. George A.J.T., Lee L. and Pitzalis C.

Isolating ligands specific for human vasculature using in vivo phage selection.

Trends in Biotechnology, (2003); 21:199-203.


  1. Chan C., Lechler R.I. and George A.J.T.

Tolerance mechanisms and recent progress.

Transplantation Proceedings, (2004); 36: 561S-569S.


  1. George A.J.T. and Larkin D.F.P.

Corneal transplantation – the forgotten graft.

         American Journal of Transplantation, (2004); 4: 678-685.


  1. Tan P.H., Chan C.L.H., Chan C. and George A.J.T.

Evolving role of gene-based treatment in surgery

British Journal of Surgery, (2005); 92: 1466-1480.


  1. George A.J.T., Stark J. and Chan C.

Understanding specificity and sensitivity of T-cell recognition.

         Trends in Immunology, (2005); 12: 653-659.


  1. Tan P.H. Chan C.L.H. and George A.J.T.

Strategies to improve non-viral vectors – potential applications in clinical transplantation.

         Expert Opinion on Biological Therapy, (2006); 6: 619-630.


  1. Soleimani B., Lechler R.I., Hornick P.I. and George A.J.T.

Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation.

         American Journal of Transplantation, (2006); 6: 1781-1785.


  1. Tan P.H., Tan P.L., George A.J.T. and Chan C.L.H.

Gene therapy for transplantation with viral vectors – how much of the promise has been realised?

Expert Opinion on Biological Therapy, (2006): 6; 759-772.


  1. George A.J.T., Bhakoo K.K., Haskard D.O., Larkman D.J. and Reynolds P.R.

Imaging molecular and cellular events in transplantation.

Transplantation, (2006): 82; 1124-1129.


  1. Tan P.H., George A.J.T. and Handa A.I.

Gene therapy for clinical transplantation: where do we stand in 2006?

         Discovery Medicine, (2006): 34; 153-156


  1. Stark J., Chan C. and George A.J.T.

Oscillations in the immune system.

Immunological Reviews, (2007); 216: 213-231.


  1. Manunta M., Tan P.H. and George A.J.T.

Modulation of the immune response by targeting endothelial cells.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, (2007); 6: 169-178.


  1. Fu H., Larkin D.F.P. and George A.J.T.

Immune modulation in corneal transplantation.

Transplantation Reviews, (2008); 22: 105-115.


  1. Hansel T.V., Kropshofer H., Singer T., Mitchell J.A. and George A.J.T.

The safety and side effects of monoclonal antibodies.

Nature Reviews Drug Discovery, (2010); 9: 325-338.


  1. Mouratidis PX, George A.J.T.

Transfection of indoleamine 2,3 dioxygenase in primary endothelial cells.

Methods Mol Biol., (2010); 616:149-159.


  1. Anderson-Ford D and George A.

Review of the regulatory and governance environment for medical research in the UK with a particular focus on clinical trials. The Academy of Medical Sciences – call for evidence.

Research Ethics Review, (2010); 6: 108-113.


  1. Zhao H., Perez J.S., Lu K., George A.J.T. and Ma D.

Role of Toll-like receptor 4 in renal graft ischemia-reperfusion injury.

American Journal of Physiology-Renal Physiology, (2014); 306: F801-F811.


  1. George A.J.T., Collett C., Carr A., Holm S., Bale C., Burton S., Campbell M., Coles A., Gottlieb G., Muir K., Parroy S., Price J., Rice A.S.C., Sinden J., Stephenson C., Wartolowska K. and Whittall H.

When should placebo surgery as a control in clinical trials be carried out?

Bulletin of the Royal College of Surgeons (2016); 98: 75-79.


  1. Zhao H., Alam A., Soo A.P., George A.J.T. and Ma D.

Ischemia-reperfusion injury reduces long term renal graft survival: mechanism and beyond.

EBioMedicine (2018); in press.


Patent Reviews


  1. George A.J.T. and Haskard D.O.

Generation of a neutral antibody against E-selectin.

Expert Opinion on Therapeutic Patents, (1996); 6: 789-793.


  1. George A.J.T.

Production in yeasts of stable recombinant antibody fragments.

Expert Opinion on Therapeutic Patents, (1997); 7: 179-183.


  1. George A.J.T.

Peptide mimetics of carbohydrate epitopes: strategies to block hyperacute rejection of porcine xenografts.

Expert Opinion on Therapeutic Patents, (1997); 7: 1345-1350.


  1. George A.J.T.

Transgenic non-human animals capable of producing heterologous antibodies.

Expert Opinion on Therapeutic Patents, (1998); 8: 1185-1189.


Teaching Related Articles:


  1. George A.J.T., Ritter M.A and Urch C.E.

Research training and Calman reforms: a role for the MSc?

Postgraduate Medical Journal, (1996); 72: 321-322.


  1. George A.J.T, Hughes S.P.F., Urch C.E. and Ritter M.A.

Science and research education for surgical trainees.

Scalpel, (1996); 14(2): 1-2.


  1. George A.J.T. and Hornick P.

Molecular biology: part I.

Surgery, (1996); 14(5): 108a-108d.


  1. George A.J.T. and Hornick P.

Molecular biology: part II.

Surgery, (1996); 14(6): i-iii.


  1. George A.J.T. and Hornick P.

Molecular biology: part III.

Surgery, (1996); 14(7): 156a-156c.


  1. George A.J.T.

Immunity part 1: induction of the immune response

Surgery, (1997); 15(7): 156a-156d.


  1. George A.J.T.

Immunity part 2: effector phase of the response

Surgery, (1997); 15(8): 180a-180c.


  1. George A.J.T.

Do I have to wear my genes? Genetic determinism and the Priesthood.

Ministry Today (2003); 27: 21-26.


  1. George A.J.T.

Cloning Jesus.

Ministry Today (2004); 31: 27-32.


  1. George A.J.T.

Research Ethics.

Medicine (2016); 44: 615-618.



Book Chapters:


  1. Segal D.M., Urch C.E., George A.J.T. and Jost C.R.

Bispecific antibodies in cancer treatment.

In: Biologic Therapy of Cancer Update, Volume 2. DeVita V.T., Hellman S. and Rosenberg S.A. (eds). Lippincott (Philadelphia), (1992) 1-12.


  1. Segal D.M., Jost, C.R. and George A.J.T.

Targeted cellular cytotoxicity.

In: Cytotoxic Cells: Generation, Recognition, Effector Functions, Methods. M. Sitkovsky and P.A. Henkart (eds). Burkhäuser (Boston), (1993) 96-110.


  1. George A.J.T.

Production of antibodies using phage display libraries.

In: Monoclonal Antibodies; Production, Engineering and Clinical Applications. M.A. Ritter and H.M. Ladyman (eds). Cambridge University Press (Cambridge), (1995) 142-165.


  1. Huston J.S., George A.J.T., Tai M.-S., McCartney J.E., Jin D., Segal D.M., and Opperman H.

Single-chain Fv design and production by preparative folding.

In: Antibody Engineering: A Practical Approach. Second edition. C. Borrebaeck (ed), Oxford University Press (Oxford), (1995) 185-225.


  1. George A.J.T.

Animal biotechnology in medicine.

In: Animal Biotechnology and Ethics. Holland A. and Johnson A. (eds), Chapman and Hall (London), (1997) 27-49.


  1. George A.J.T.

Antibody engineering: potential applications for immunoassays.

In: Principles and Practice of Immunoassay. Second edition. C.P. Price and D.J. Newman (eds). Macmillan Press (London), (1997) 65-98.


  1. George A.J.T. and Huston J.S.

Bispecific antibody engineering.

In: The Antibodies, Volume 4. M. Zanetti and J.D. Capra (eds). Harwood Academic Publishers (Luxembourg), (1997) 99-141.


  1. George A.J.T.

Measurement of the kinetics of biomolecular interactions using the IAsys resonant mirror biosensor.

In: Current Protocols in Immunology. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M. and Strober W. (eds). John Wiley & Sons, Inc (New York), (1998) section 18.5.


  1. George A.J.T.

The antibody molecule.

In: Diagnostic and Therapeutic Antibodies. George A.J.T. and Urch C.E. (eds). Humana Press (Totowa, New Jersey), (2000) 1-21.


  1. George A.J.T.

Use of biosensors to measure the kinetics of antibody-antigen interactions.

In: Diagnostic and Therapeutic Antibodies. George A.J.T. and Urch C.E. (eds.). Humana Press (Totowa, New Jersey), (2000) 363-372.


  1. George A.J.T. and Lechler R.I.

Xenotransplantation: will pigs fly?

In: Future Strategies for Tissue and Organ Replacement Polak J.M., Hench L.L. and Kemp P. (eds)

Imperial College Press (London), (2002) 215-236.


  1. George A.J.T.

Monoclonal antibody therapy.

In: Topley & Wilson’s Microbiology and Microbial Infections, Immunology, 10th Edition. Steward M.W. and Kauffmann S.H.E. (eds)

Hodder Arnold (London), (2005) 353-374.


  1. Lechler R.I. and George A.J.T.

Transplantation and Rejection.

In: Immunology 7th Edition. Male D., Brostoff J., Roth D.B. and Roitt I. (eds)

Mosby Elsevier (Philadelphia), (2006) 383-399.


  1. George A.J.T. contributor to Wigley C

Blood Lymphoid Tissues and Haemopoiesis.

In: Gray’s Anatomy 40th Edition. Standring S. (ed. in chief)

Churchill Livingstone (London), (2008) 67-80.


  1. George A.J.T.


In: Basic Science in Obstetrics and Gynaecology 4th Edition. Bennett P. And Williamson C. (eds)

Churchill Livingstone Elsevier (Edinburgh), (2010) 131-142.


  1. Seow W.Y. and George A.J.T.

Peptides as Promising Non-Viral Vectors for Gene Therapy.

In: Non-viral Gene Therapy Yuan X.B. (ed)

Intech (Rijeka, Croatia), (2011) 615-644.


17     George A.J.T.

Transplantation and Rejection.

In: Immunology 8th Edition. Male D., Brostoff J., Roth D.B. and Roitt I.M. (eds)

Mosby Elsevier (Philadelphia), (2012) 341-353.


  1. George A.J.T

Blood, Lymphoid Tissues and Haemopoiesis.

In: Gray’s Anatomy 41st Edition. Standring S. (ed. in chief)

Churchill Livingstone (London), (2015) 68-80.


  1. George A.J.T.

Ethical and Legal Issues in Clinical Research.

In: Ethical and Legal Issues in Modern Surgery. Hakin N., Papalois V. and Epstein M. (eds)

Imperial College Press (London), (2015) 95-114.


Conference Proceedings:


  1. Stevenson F.K., George A.J.T., Tutt A.L., Glennie M.J. and Stevenson G.T.

Involvement of innate and induced anti-idiotypic mechanisms in suppression of B cell tumours.

Monographs in Allergy, (1987); 22: 184-193.


  1. Segal D.M., Qian J.-H., Titus J.A., Moreno M.B., George A.J.T., Jost C.R., Kurucz I., El-Gamil M. and Wunderlich J.R.

Targeted cytokine production.

International Journal of Cancer, (1992); S7: 36-38.


  1. Andrew S.M., Perez P., Nicolls P.J., George A.J.T., Huston J.S., Oppermann H. and Segal D.M.

Production of a single chain bispecific antibody by recombinant DNA technology.

In: Bispecific antibodies and targeted cellular cytotoxicity. Romet-Lemonne J.-P., Fanger N.W. and Segal D.M. (eds). Fondation Nationale de Transfusion Sanguine (Les Ulis, France), (1991), 197-199.


  1. Stevenson F.K., Dyke R.J., King C.A., George A.J.T. and Hamblin T.J.

Idiotypic vaccination against B-cell lymphoma leads to dormant tumor.

In: Cellular Immune Mechanisms and Tumor Dormancy. Stewart T.H.M. and Wheelock E.F. (eds). CRC Press (Boca Raton), (1992), 71-80.


  1. Segal D.M., Qian J.-H., Mezzanzanica D., Garrido M.A., Titus J.A., Andrew S.M., George A.J.T., Jost J.R., Perez P. and Wunderlich J.R.

Targeting of anti-tumor responses with bispecific antibodies.

Immunobiology, (1992); 185: 390-402.


  1. George A.J.T., Titus J.A., Jost C.R., Kurucz I., Perez P., Andrew S.M., Nicholls P.J., Huston J.S. and Segal D.M.

Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv molecules.

Cell Biophysics, (1995); 26: 153-165.


  1. Hussain R., Siligardi G., Adebakin S., Cook J.A., George A.J.T., Drake A.F. and Courtenay-Luck N.S.

Tumour-imaging peptides: conformation-activity relationship by cd spectroscopy.

In: Peptides: Chemistry, Structure and Biology. Kaumaya P.T.P. and Hodges R.S. (eds), Mayflower Scientific Ltd. (England), (1996), 808-809.


  1. George A.J.T., Arancibia-Cárcamo C.V., Awad H.M., Comer R.M., Fehevari Z., King W.J., Kadifachi M., Hudde T., Kerouedan-Lebossé C., Mirza F., Oral H.B., Rayner S.A., Tan P.H., Tay E. and Larkin D.F.P.

Gene delivery to the corneal endothelium.

         American Journal of Respiratory and Critical Care Medicine, (2000); 163: S194-S200.


  1. George A.J.T.

Antibody Engineering – IBC’s 12th Annual International Conference

Investigational Drugs weekly highlights, (January 2002): 63-68.


  1. George A.J.T.

Transplantation Society–XXth International Congress. 5-10 September 2004, Vienna, Austria.

         IDrugs (2004); 7: 984-986.


  1. George A.J.T.

Dendritic cells in cancer immunotherapy

IDrugs (2005); 8: 104-106.


Correspondence, Editorials, Book Reviews and on line articles:


  1. George A.J.T. and Ritter M.A.

Fundamental immunology (3rd edn) (book review).

Immunology Today, (1994); 15: 392.


  1. Ritter M.A. and George A.J.T.

Thymic involution: Why bother? – a reply.

Immunology Today, (1996); 17: 493.


  1. George A.J.T,

Antibody engineering. A practical approach (book review).

Society for General Microbiology Quarterly, (1997); 24: 114


  1. George A.J.T.

Small but perfectly formed (book review).

The Times Higher Education Supplement; (1997); August 8: 23.


  1. George A.J.T. and Urch C.E.

A case of using the right and proper title.

BMA News Review, (1997); 23(12): 6.


  1. George A.J.T. and Ritter M.A.

Immunological techniques on video (video review).

Immunology News, (1998); 5: 47-48.


  1. George A.J.T.

Combinatorial Peptide Library Protocols (book review).

Journal of Immunological Methods, (1998); 218: 169-171.


  1. George A.J.T.

Antibody engineering: an introduction (editorial).

         Journal of Immunological Methods, (1999); 231: 1.


  1. George A.J.T. and Gray D.

Jumping or walking: which is better?

         Immunology Today, (2000); 21: 56.


  1. George A.J.T.

A Companion to Genethics.

Ministry Today, (2003); 27: 40-41.


  1. Yang YY, George AJ, Kataoka K, Luo D, Wang S.

Macromolecular synthetic biomaterials for delivery of therapeutics.

Macromolecular Rapid Communications (2010); 31:1121.


  1. Kirkbride J. and George A.J.T.

Lay REC members: patient and public.

Journal of Medical Ethics (2013); doi:10.1136/medethics-2012-100642


  1. George A.J.T.

Judging Jenner: was his smallpox experiment really unethical?

The Conversation (2016); February 16



  1. George A.J.T.

We should use placebos more often, especially in surgery.

The Conversation (2016); March 10


Wir brauchen mehr Placebos – gerade in der Chirurgie.

Medinside (2016); March 30



  1. George A.J.T. and Irani Z.

One aspect of student debt really doesn’t add up.

University Business (2016); March 26



  1. George A.J.T.

How the British defeated Napoleon with citrus fruit.

The Conversation (2016); May 19



  1. George A.J.T.

Baron Larrey – Napoleonic inventor of ambulances, triage and MASH.

The Conversation (2016); July 8


Le baron Larrey, ce génie à qui l’on doit l’ambulance… et la série « MASH ».

The Conversation, French edition (2016); July 8



  1. Giannoulopoulos D., Petley J., Roberts J., George A., Leahy W., Braganza A., Choo A., Crosby S., King C., Knowles J., Mitsilegas V., Rehman J., Rosen D., Shah P., Well and J., Xanthaki A.,

The status of EU citizens in the UK requires immediate attention.

Guardian letters (July 11, 2016);



  1. George A.J.T.

The antibodies that were invented to help immunologists find GOD.

The Conversation (2016); September 29



  1. George A.J.T.

Brexit and Higher Education.

In: Brexit: opportunities, challenges and the road ahead. Giannoulopoulos D. (ed)

Britain in Europe Policy Report, (2016) 36-41. http://media.wix.com/ugd/e6ec6f_a617701927ef4eabb44123a72848e989.pdf


  1. George A.J.T.

Antibodies are not magic bullets – more like sticky drunkards.

The Conversation (2017); August 21



  1. George A.J.T.

Be wary: animations risk embedding confused metaphors.

Education Technology and University Business (2017); September 5




  1. George A.J.T.

Universities must ease the pains of bondage.

Times Higher Education (2017); November 16, 30.



  1. George A.J.T.

Universities – locally rooted but globally connected.

Wonkhe (2017); November 23



  1. George A.J.T.

Local to global, how can universities support internationalisation with their business partners?

National Centre for Universities and Business (NCUB) (2017); November 24



  1. George A.J.T.

Has the doctoral thesis passed its sell-by date?

Wonkhe (2018); January 17

Has the doctoral thesis passed its sell-by date?


  1. George A.J.T.

Can we rank social mobility?

Wonkhe (2018); February 1

Can we rank social mobility?